一个不偏见的屏幕确定了Hsp70-BAG3复合体作为肌结合蛋白C3的调节者
Andrea D Thompson1, Marcus J Wagner2, Juliani Rodriguez1
1Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, USA.
家庭性多变性心肌病 (HCM) 与MYBPC3基因变异有关. 研究人员发现热冲击蛋白70和BAG3调节MyBP-C蛋白水平,为HCM提供潜在的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 遗传心脏病学 遗传心脏病学
背景情况:
- 家庭性多变性心肌病 (HCM) 是一种主要的遗传性心肌疾病.
- MYBPC3基因变异对约50%的家族性HCM病例负责.
- 肌结合蛋白C (MyBP-C) 的水平降低是MYBPC3变种引起的HCM的标志.
研究的目的:
- 确定调节MyBP-C蛋白质平衡的新途径.
- 通过了解MyBP-C调控来发现HCM的潜在治疗点.
主要方法:
- 选了2,426种生物活性化合物,以确定MyBP-C水平的调节剂.
- 使用了JG98,一种热冲击蛋白70 (HSP70) 的全调节器.
- 通过对BAG3.3的基因操纵,研究了HSP70-BAG3复合体在MyBP-C蛋白稳定性中的作用.
主要成果:
- 鉴定了JG98,它抑制了HSP70与BAG域共同伴侣的相互作用.
- 证明JG98治疗可以降低MyBP-C蛋白水平.
- 表明BAG3的遗传减少模仿了JG98的效应,降低了MYBPC3蛋白水平.
结论:
- 热冲击蛋白70-BAG3复合体是MyBP-C蛋白稳定性的新型调节者.
- 这一发现为MyBP-C平衡提供了新的理解.
- 通过准HSP70-BAG3通路,确定了对HCM的潜在治疗途径.
更多相关视频
09:17Author Spotlight: Unraveling the Role of Myosin-7a and Usher Proteins in Hearing and Human Disease
Published on: August 23, 2024
10:24Defining Hsp33's Redox-regulated Chaperone Activity and Mapping Conformational Changes on Hsp33 Using Hydrogen-deuterium Exchange Mass Spectrometry
Published on: June 7, 2018
相关概念视频
Regulation of Nuclear Protein Sorting
Microtubule Associated Proteins (MAPs)
Overview of Myosin Structure and Function
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
